Victor Williams

107 4 Diabetes-tuberculosis comorbidity in a low-income setting References 1. World Health Organisation. Global Tuberculosis Report 2021: TB and Diabetes [Internet]. Geneva: WHO; 2021 Oct. Available from: https://www.who.int/publications/digital/global-tuberculosisreport-2021/featured-topics/tb-diabetes 2. International Diabetes Federation. IDF diabetes atlas tenth edition 2021 [Internet]. Brussels. Belgium: International Diabetes Federation; 2021 [cited 2023 Aug 21]. Available from: https:// diabetesatlas.org/atlas/tenth-edition/ 3. World Health Organisation. COVID-19 and TB. Global Tuberculosis Report 2021 [Internet]. Geneva: WHO; [cited 2023 Aug 21]. Available from: https://www.who.int/publications/digital/globaltuberculosis-report-2021/covid-19 4. Dheda K, Perumal T, Moultrie H, Perumal R, Esmail A, Scott AJ, et al. The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions. Lancet Respir Med [Internet]. 2022 Jun [cited 2023 Aug 21];10(6):603–22. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942481/ 5. The Stop TB Partnership. 12 Months of COVID-19 Eliminated 12 Years of Progress in the Global Fight Against Tuberculosis [Internet]. 2021 [cited 2023 Aug 21]. Available from: https://www. stoptb.org/news/12-months-of-covid-19-eliminated-12-years-of-progress-global-fight-againsttuberculosis 6. Rumende CM. Risk Factors for Multidrug-resistant Tuberculosis. Acta Med Indones. 2018 Jan;50(1):1–2. 7. Chen Z, Liu Q, Song R, Zhang W, Wang T, Lian Z, et al. The association of glycemic level and prevalence of tuberculosis: a meta-analysis. BMC Endocr Disord. 2021 Jun 16;21(1):123. 8. Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lönnroth K, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011 Jul 1;9:81. 9. Al-Rifai RH, Pearson F, Critchley JA, Abu-Raddad LJ. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PLoS One. 2017;12(11):e0187967. 10. World Health Organisation. Framework for collaborative action on tuberculosis and comorbidities [Internet]. Geneva: WHO; 2022 Oct [cited 2023 Aug 22]. Available from: https://www.who.int/ publications/i/item/9789240055056 11. World Health Organisation. Integrating the prevention and control of non-communicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: Implementation Guidance [Internet]. Geneva: WHO; 2023. Available from: https://www.who.int/publications/i/ item/9789240061682 12. Noubiap JJ, Nansseu JR, Nyaga UF, Nkeck JR, Endomba FT, Kaze AD, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis. Lancet Glob Health. 2019 Apr;7(4):e448–60. 13. Workneh MH, Bjune GA, Yimer SA. Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review. PLoS One. 2017;12(4):e0175925. 14. Mabula PL, Kazinyingia KI, Chavala EC, Mosha V, Msuya SE, Leyaro BJ. Prevalence and risk factors for diabetes mellitus among tuberculosis patients in Moshi Municipal Council, Kilimanjaro Tanzania. East Afr Health Res J. 2021;5(1):69–74.

RkJQdWJsaXNoZXIy MTk4NDMw